Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
173.89
-1.01 (-0.58%)
At close: Apr 2, 2026, 4:00 PM EDT
172.00
-1.89 (-1.09%)
After-hours: Apr 2, 2026, 7:44 PM EDT
CRL Stock Forecast
Stock Price Forecast
The 11 analysts that cover CRL stock have a consensus rating of "Buy" and an average price target of $200.09, which forecasts a 15.07% increase in the stock price over the next year. The lowest target is $175 and the highest is $265.
Price Target: $200.09 (+15.07%)
Analyst Consensus: Buy
* Price targets were last updated on Feb 25, 2026.
Analyst Ratings
The average analyst rating for CRL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 9 | 7 | 6 | 6 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 14 | 14 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $170 → $175 | Hold | Maintains | $170 → $175 | +0.64% | Feb 25, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $251 → $235 | Strong Buy | Maintains | $251 → $235 | +35.14% | Feb 20, 2026 |
| Mizuho | Mizuho | Hold Maintains $215 → $175 | Hold | Maintains | $215 → $175 | +0.64% | Feb 20, 2026 |
| Barclays | Barclays | Buy Maintains $215 → $200 | Buy | Maintains | $215 → $200 | +15.02% | Feb 19, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $260 → $200 | Buy | Maintains | $260 → $200 | +15.02% | Feb 19, 2026 |
Financial Forecast
Revenue This Year
4.06B
from 4.02B
Increased by 0.99%
Revenue Next Year
4.19B
from 4.06B
Increased by 3.26%
EPS This Year
11.15
from -2.91
EPS Next Year
12.16
from 11.15
Increased by 9.01%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.3B | 4.6B | |||
| Avg | 4.1B | 4.2B | |||
| Low | 3.8B | 3.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 7.1% | 12.4% | |||
| Avg | 1.0% | 3.3% | |||
| Low | -6.5% | -6.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.30 | 13.74 | |||
| Avg | 11.15 | 12.16 | |||
| Low | 10.65 | 10.96 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 23.2% | |||
| Avg | - | 9.0% | |||
| Low | - | -1.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.